- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05975177
Evaluation of the Efficacy of STERIFY GEL in the Treatment of Periodontitis Following Scaling and Root Planing (SFYCT)
Evaluation of the Efficacy and Safety of STERIFY GEL in the Treatment of Periodontitis Following Scaling and Root Planing: Pivotal, Prospective, Single-center, Split-mouth, Randomized, Controlled Study
The purpose of this clinical study is to evaluate the safety and efficacy of treating periodontal disease with the STERIFY GEL medical device in combination with SRP procedure, in terms of periodontal pocket healing. Efficacy will be compared with the use of the nonsurgical SRP technique alone, which is considered a gold standard treatment for periodontitis, with the aim of observing improved results when using the STERIFY GEL device.
The study is prospective, split-mouth.STERIFY GEL will be administered into the periodontal pockets of one or two segments of patients undergoing whole-mouth extended SRP, with the contralateral segments serving as controls (split-mouth), in a single session.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of the study is to test the safety and efficacy of STERIFY GEL in promoting healing of periodontal pockets following SRP, compared with treatment with SRP alone. With specific visco-elastic and mucoadhesive properties, STERIFY GEL easily penetrates into the deepest and hard-to-reach areas of periodontal and peri-implant pockets, adhering to the gingival tissue and alveolar bone, providing complete coverage of the pockets. The effect of STERIFY GEL is promoted by a physical mechanism of action. After SRP, the gel is applied into the gingival pocket, where it acts primarily as a filler to restore volume, physically preventing bacteria from entering and reinfecting the pocket. STERIFY GEL can thus mechanically protect treated pockets and bone defects, promoting tissue healing. The occluding action at the level of periodontal and peri-implant gingival pockets, in synergy with the accessory action of hydroxytyrosol, nisin, and magnesium ascorbyl phosphate, prevents bacterial recolonization and promotes subsequent tissue regeneration.
Although SRP surgery is considered a gold standard treatment for periodontitis, it may in some cases be insufficient to decontaminate the pocket allowing bacteria to recolonize the tissues promoting new inflammation that can worsen the clinical picture.STERIFY GEL may find useful application in cases of moderate to severe chronic periodontal disease as an adjunctive treatment following SRP to improve and accelerate healing parameters and prevent recurrent inflammation and infection.In addition, antimicrobial control action prevents antibiotic use and the risk associated with antibiotic resistance.Such control of periodontal disease also allows for the maintenance of patients who cannot undergo surgical treatment (e.g., patients on bisphosphonate therapy, defected etc.).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Varese, Italy, 21100
- Odontostomatologia, ASST dei Sette Laghi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with grade III and IV chronic periodontal disease according to the European Federation of Periodontology classification involving at least two sites
- Adherence to the study and signing of informed consent
- Major age- Participants with a minimum of 6 teeth with periodontal pocket depth greater than 5mm- Participants with at least 20 teeth
Exclusion Criteria:
- Established hypersensitivity to one or more components of the device- Pregnancy or lactation- Heavy smoker (more than 9 cigarettes per day)- Concomitant dental disease, except periodontitis, or planned treatment that may interfere with the study or study procedure, such as dental surgery or tooth implantation- Diabetes mellitus, rheumatoid arthritis, or other chronic diseases that may affect disease or treatment
- Aggressive periodontitis
- History of radiation or chemotherapy
- Autoimmune mucosal diseases
- Mental illnesses
- Parafunctions such as bruxism
- Use of antibiotics in the past 3 months
- Periodontal surgeries in the past 12 months in the areas covered by the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sterify Gel + SRP
Scaling and root planing in the assigned site, followed by intra-pocket administration of Sterify Gel, applied to the bottom of the pocket until the gel emerges or becomes visible at the gingival margin
|
A mucoadhesive polymeric hydrogel in a prefilled syringe for nonsurgical treatment of periodontal and peri-implant pockets, composed of polyvinyl polymers, hydroxytyrosol, nisin, and magnesium ascorbyl phosphate
The non-surgical procedure involved SRP under local anesthesia with EMS scalers and Gracey curettes.
|
|
Active Comparator: SRP only
Scaling and root planing in the assigned site.
|
The non-surgical procedure involved SRP under local anesthesia with EMS scalers and Gracey curettes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pocket Depth
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
Measurement by periodontal probe of periodontal pocket depth.
Unit of measurement in mm with a sensitivity of 0.5 mm.
|
Pre-treatment, 1 month, 2 months, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gingival recession
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
Measurement by periodontal probe of the distance from the cemento-enamel junction to the depth of the free gingival margin.
|
Pre-treatment, 1 month, 2 months, 3 months
|
|
Clinical Attachment Level
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
Measurement by periodontal probe of the distance in millimeters between the amelo-cement junction (the boundary between the crown and root of the tooth) and the bottom of the pocket.It can also be calculated by summing the gingival recession and the periodontal pocket.
|
Pre-treatment, 1 month, 2 months, 3 months
|
|
Bleeding Index
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
% measurement.
Each site is gently probed with a periodontal probe at six sites (mesial, middle, and distal on both buccal and lingual surfaces): bleeding is assessed as present or absent, and the number of sites where bleeding is present is recorded.The number of sites where bleeding is recorded is divided by the total number of sites available in the mouth and multiplied by 100 to express the bleeding index as a percentage.
|
Pre-treatment, 1 month, 2 months, 3 months
|
|
Furcations
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
0: no furcation1: horizontal loss of supporting tissues not exceeding one third of the tooth width 2: horizontal loss of supporting tissues exceeding one-third of the tooth width but not affecting the entire furcation 3: Horizontal loss of supporting tissues "passing through" the entire furcation area.
|
Pre-treatment, 1 month, 2 months, 3 months
|
|
Grade of Mobility
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
The survey of dental mobility completes the objective examination. It is important to remember that mobility can be periodontal, traumatic, or endodontic in origin and should be assessed by the application of slight forces conveyed through two instruments and not with the fingers. Class 0: physiological mobility.Class 1: slightly increased mobility, slight horizontal displacements (Perceptible mobility <1mm in buccolingual direction) Class 2: markedly increased mobility without functional impediment, displacements in horizontal direction (>1mm but <2mm) Class 3: markedly increased mobility with functional impediment, displacements even in vertical direction (>2mm or depressibility in the socket) |
Pre-treatment, 1 month, 2 months, 3 months
|
|
Plaque Index
Time Frame: Pre-treatment, 1 month, 2 months, 3 months
|
The plaque index (PI) (Silness J & Löe H), is recorded, during the clinical periodontal examination, at 4 to 6 sites for each tooth element present by circumferential probing with a manual periodontal probe.The 6 dental sites considered are: buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual, and disto-lingual (if there are 4: distal, proximal, palatine/lingual, buccal).Each site is given a score from 0 to 3, where: 0 no plaque, 3 abundance of plaque.
|
Pre-treatment, 1 month, 2 months, 3 months
|
|
Quantification of bacterial contamination
Time Frame: Pre-treatment, 3 months
|
Bacterial contamination assessed through quantitative PCR.
|
Pre-treatment, 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SFYCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parodontitis
-
Centre Hospitalier Universitaire de NiceCompletedParodontitis Aggressive | Parodontitis ChronicFrance
-
Centre Hospitalier Universitaire de la RéunionUnknownObesity | Parodontitis | Metabolism DisordersRéunion
-
University Hospital, ToulouseRecruiting
-
German Institute of Human NutritionPraxis am Posthof, Hameln, GermanyCompletedType2 Diabetes | ParodontitisGermany
Clinical Trials on Sterify Gel
-
University of PaviaRecruitingPeri-implantitis | Dental Implants | Non-surgical Periodontal TherapyItaly
-
Starpharma Pty LtdCompletedBacterial VaginosisUnited States
-
Glyciome, LLCBrigham and Women's Hospital; University of Puerto RicoCompletedSensory Perceptual Characteristics | User Acceptability of Gel Delivery SystemUnited States, Puerto Rico
-
Novan, Inc.CompletedAcne VulgarisDominican Republic, Honduras, Panama
-
Starpharma Pty LtdCompletedRecurrent Bacterial Vaginosis (BV)
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
Alcon ResearchCompleted
-
DermBiont, Inc.Active, not recruiting
-
Yaso Therapeutics CorporationEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingEarly-phase Safety and PK Study of a Vaginal GelUnited States
-
Maha ZuhairCompletedDental Implants , Osseointegration , Marginal Bone Loss , Implant StabilityIraq